Phenazine

Phenazine

SCHEMBL22631548

O=S(=O)(O)OO.c1ccc2nc3ccccc3nc2c1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.55
ALDH1A1 P00352 7/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
NQO2 P16083 5/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KMT2A Q03164 4/20 0.41
RAB9A P51151 4/20 0.41
GAA P10253 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 4/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 3/20 0.41
USP2 O75604 1/20 0.41
CACNA1B Q00975 1/20 0.41
APBA1 Q02410 1/20 0.41
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.40
AHR P35869 1/20 0.40
GLA P06280 1/20 0.40
ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenazine SCHEMBL2923781 0.87 MAPT (0.65) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL8564741 0.87 MAPT (0.65) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL10876543 0.86 MAPT (0.50) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL2873102 0.86 MAPT (0.50) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL94396 0.86 MAPT (0.50) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL28835271 0.84 MAPT (0.61) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL23522712 0.82 MAPT (0.58) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL23522711 0.82 MAPT (0.58) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL1750964 0.82 MAPT (0.58) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1
Phenazine SCHEMBL7095188 0.81 MAPT (0.44) MAPTALDH1A1SMN1; SMN2NQO2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023028041-A1 ELECTROCHEMICAL REBALANCING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-03-02 WO disclosed
US-20210060484-A1 PROTON COUPLED ELECTROCHEMICAL CO2 CAPTURE SYSTEM NATIONAL SCIENCE FOUNDATION 2021-03-04 US disclosed
EP-3735311-A1 <SUP2/><SUB2/> 2 PROTON COUPLED ELECTROCHEMICAL COCAPTURE SYSTEM President and Fellows of Harvard College (US) 2020-11-11 EP disclosed